GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apex Biotechnology Corp (TPE:1733) » Definitions » Net Margin %

Apex Biotechnology (TPE:1733) Net Margin % : 6.47% (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Apex Biotechnology Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Apex Biotechnology's Net Income for the three months ended in Mar. 2024 was NT$29 Mil. Apex Biotechnology's Revenue for the three months ended in Mar. 2024 was NT$451 Mil. Therefore, Apex Biotechnology's net margin for the quarter that ended in Mar. 2024 was 6.47%.

The historical rank and industry rank for Apex Biotechnology's Net Margin % or its related term are showing as below:

TPE:1733' s Net Margin % Range Over the Past 10 Years
Min: 0.18   Med: 6.05   Max: 15.28
Current: 6.46


TPE:1733's Net Margin % is ranked better than
80.37% of 1029 companies
in the Biotechnology industry
Industry Median: -154.15 vs TPE:1733: 6.46

Apex Biotechnology Net Margin % Historical Data

The historical data trend for Apex Biotechnology's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apex Biotechnology Net Margin % Chart

Apex Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.18 4.73 9.49 8.10 6.91

Apex Biotechnology Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.19 6.48 9.18 3.70 6.47

Competitive Comparison of Apex Biotechnology's Net Margin %

For the Biotechnology subindustry, Apex Biotechnology's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apex Biotechnology's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Apex Biotechnology's Net Margin % distribution charts can be found below:

* The bar in red indicates where Apex Biotechnology's Net Margin % falls into.



Apex Biotechnology Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Apex Biotechnology's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=115.783/1676.537
=6.91 %

Apex Biotechnology's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=29.142/450.658
=6.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Apex Biotechnology  (TPE:1733) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Apex Biotechnology Net Margin % Related Terms

Thank you for viewing the detailed overview of Apex Biotechnology's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Apex Biotechnology (TPE:1733) Business Description

Traded in Other Exchanges
N/A
Address
No.7, Li-Hsin 5th Road, Hsinchu Science Park, Hsinchu, TWN, 30078
Apex Biotechnology Corp engages mainly in research, development, production, manufacturing and selling of biochemical testing instruments and its detection strips, and trade of products and components relevant to the core business. The company develops and markets biosensor-based blood glucose monitoring systems. The company manufactures non-invasive diagnostic technologies, IT-based telehealth care and molecular diagnostic and traditional Chinese medicine. Its product offerings include Eclipse plus multipurpose analyzer, Glucosure HT blood glucose monitoring system, HemoSmart GOLD hemoglobin screening system among others.

Apex Biotechnology (TPE:1733) Headlines

No Headlines